Novel glycol chitosan-based polymeric gene carrier synthesized by a Michael addition reaction with low molecular weight polyethylenimine

被引:24
作者
Lee, Young Hwa [1 ]
Park, Hae In [1 ]
Choi, Joon Sig [1 ]
机构
[1] Chungnam Natl Univ, Dept Biochem, Taejon 305764, South Korea
基金
新加坡国家研究基金会;
关键词
Glycol chitosan; Polyethylenimine; Nanorod; Gene delivery; TRANSFECTION EFFICIENCY; DELIVERY-SYSTEMS; DNA NANOPARTICLES; NONVIRAL VECTOR; CELLULAR UPTAKE; GRAFT-POLYETHYLENIMINE; MEDIATED ENDOCYTOSIS; PAMAM DENDRIMER; DRUG-DELIVERY; THERAPY;
D O I
10.1016/j.carbpol.2015.10.089
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
A glycol chitosan-based polymer that spontaneously assembles with plasmid DNA into nanorods was evaluated as a non-viral vector for gene delivery. Glycol chitosan-methyl acrylate-polyethylenimine (GMP) was synthesized by grafting polyethylenimine onto glycol chitosan via amidation after Michael addition using methyl acrylate. Gel retardation and PicoGreen assay experiments showed complete complex formation with plasmid DNA. GMP/pDNA complexes were characterized using biophysical techniques and were found to be positively charged rod-shape structures with widths in the nanometer scale and lengths in the micrometer scale. Transfection efficiency and cytotoxicity of GMP polymer was evaluated in human epithelial ovary carcinoma (HeLa) cells, human embryonic kidney 293 (HEK293) cells, and human hepatocellular liver carcinoma (HepG2) cells, in comparison to high molecular weight polyethylenimine, a commonly used transfection reagent. Intracellular polymer uptake was compared and confirmed by confocal microscopy. The results demonstrate that GMP, a hybrid polymer of glycol chitosan grafted with branched polyethylenimine, may serve as a promising vehicle for efficient gene delivery. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:669 / 677
页数:9
相关论文
共 51 条
[31]   Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives [J].
Neu, M ;
Fischer, D ;
Kissel, T .
JOURNAL OF GENE MEDICINE, 2005, 7 (08) :992-1009
[32]  
Nomura T, 1997, CANCER RES, V57, P2681
[33]   Current status of polymeric gene delivery systems [J].
Park, Tae Gwan ;
Jeong, Ji Hoon ;
Kim, Sung Wan .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (04) :467-486
[34]   Targeted drug delivery with dendrimers: Comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex [J].
Patri, AK ;
Kukowska-Latallo, JF ;
Baker, JR .
ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (15) :2203-2214
[35]  
Quong D, 1998, BIOTECHNOL BIOENG, V60, P124, DOI 10.1002/(SICI)1097-0290(19981005)60:1<124::AID-BIT14>3.0.CO
[36]  
2-Q
[37]   Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy [J].
Roy, K ;
Mao, HQ ;
Huang, SK ;
Leong, KW .
NATURE MEDICINE, 1999, 5 (04) :387-391
[38]   Chitosan and its derivatives for gene delivery [J].
Saranya, N. ;
Moorthi, A. ;
Saravanan, S. ;
Devi, M. Pandima ;
Selvamurugan, N. .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2011, 48 (02) :234-238
[39]   Non-viral vectors in cancer gene therapy: principles and progress [J].
Schatzlein, AG .
ANTI-CANCER DRUGS, 2001, 12 (04) :275-304
[40]   Nonionic cellulose ethers as potential drug delivery systems for periodontal anesthesia [J].
Scherlund, M ;
Brodin, A ;
Malmsten, M .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2000, 229 (02) :365-374